The weight loss drugs landscape in the UK underwent a seismic shift on 6 July 2026 when Wegovy – an injectable semaglutide – became the first GLP-1 available to buy as a daily pill. Wegovy was ...
Eli Lilly has filed six new lawsuits against U.S. entities that it alleges are selling a version of the company’s investigational weight-loss drug on the black market.
Amazon S3 on MSN
New oral weight-loss pill beats expectations in trial
An experimental oral GLP-1 drug called aleniglipron helped adults with obesity or overweight lose up to about 12% of their ...
An experimental oral GLP-1 pill matched injection-level weight loss in an early trial.
Carley is a writer, editor and social media professional. Before starting at Forbes Health, she wrote for Sleepopolis and interned at PBS and Nickelodeon. She’s a certified sleep science coach and ...
With the recent launches of Novo Nordisk’s Wegovy pill and Eli Lilly’s Foundayo, the obesity market has started to shift toward oral GLP-1 drugs. While Novo leverages its first-mover advantage with ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results